The Case for CRISPR
This blog post was written by Spencer Olesky (Lepage Strategic Adviser, Summer ’20). Following a discussion about the future of the biotechnology industry, Spencer wrote this blog post, in which he explored commercial applications of the CRISPR technology. Background In recent years, Crispr (Clustered Regularly Interspaced Short Palindromic Repeats) has […]